Aptamer BC 007’s Affinity to Specific and Less-Specific Anti-SARS-CoV-2 Neutralizing Antibodies

COVID-19 is a pandemic respiratory disease that is caused by the highly infectious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Anti-SARS-CoV-2 antibodies are essential weapons that a patient with COVID-19 has to combat the disease. When now repurposing a drug, namely an aptamer tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Haberland, Annekathrin, Krylova, Oxana, Nikolenko, Heike, Göttel, Peter, Dallmann, Andre, Müller, Johannes, Weisshoff, Hardy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157297/
https://www.ncbi.nlm.nih.gov/pubmed/34069827
http://dx.doi.org/10.3390/v13050932

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157297/
https://www.ncbi.nlm.nih.gov/pubmed/34069827
http://dx.doi.org/10.3390/v13050932

Ejemplares similares